本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ASLAN PHARMACEUTICALS LIMITED SPON ADS EACH REP 25 ORD SHS (P/S)

0.6000
+0.0000
成交量:- -
成交額:- -
市值:169.70萬
市盈率:-0.04
高:0.6000
開:0.6000
低:0.6000
收:0.6000
資料載入中...
2019/11/07

SEC問詢函

[Cover]Correspondence
2019/11/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/17

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2019/06/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/31

招股説明書

Registration statement for certain foreign private issuers
2019/04/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]